Literature DB >> 9839637

The setting up and implementation of a venous thromboembolism prophylaxis policy in clinical hospital practice.

M J McCarthy1, G Byrne, S H Silverman.   

Abstract

Clinical management policies are meant to lead to the delivery of better health care. However, as we demonstrate in this review, having an oral or written venous thromboembolism prophylaxis policy does not necessarily lead to the majority of general surgical inpatients receiving the appropriate prophylaxis. We discovered, through prospective clinical audit, that for a clinical policy to be effective in delivering the appropriate health care, it must be repeatedly scrutinized and implemented in the correct manner. Only after several rounds of the audit cycle were we able to achieve the deliverance of venous thromboembolism prophylaxis to the majority of general surgical patients on our unit. This has wider implications, not just for the implementation of a venous thromboembolism prophylaxis policy, but also for all clinical management policies, and illustrates the importance of clinical audit in clinical practice.

Entities:  

Mesh:

Year:  1998        PMID: 9839637

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  3 in total

Review 1.  A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals.

Authors:  Rebecca Tooher; Philippa Middleton; Clarabelle Pham; Robert Fitridge; Siohban Rowe; Wendy Babidge; Guy Maddern
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 2.  Bridging the gap between evidence and practice in venous thromboembolism prophylaxis: the quality improvement process.

Authors:  Franklin A Michota
Journal:  J Gen Intern Med       Date:  2007-09-22       Impact factor: 5.128

3.  Implementation of a hospital oral care protocol and recording of oral mucositis in children receiving cancer treatment : a retrospective and a prospective study.

Authors:  Akram F Qutob; Gabrielle Allen; Sumant Gue; Tamas Revesz; Richard M Logan; Dorothy Keefe
Journal:  Support Care Cancer       Date:  2012-10-26       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.